Although all RNF43 mutations were identified in the cases harboring GNAS mutations which suggest the synergistic effect of GNAS and RNF43 in the occurrence of IPMN, further research is required to determine the mechanism of action. Here, RNF43 is linked to pancreatic intraductal papillary-mucinous neoplasm.